{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:10:22Z","timestamp":1790403022399,"version":"4.1.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Patients with pathogenic variants in the GATA Binding Protein 2 (<jats:italic>GATA2<\/jats:italic>), a hematopoietic transcription factor, are at risk for human papillomavirus-related (HPV) anogenital cancer at younger than expected ages. A female cohort with <jats:italic>GATA2<\/jats:italic> haploinsufficiency was systematically assessed by two gynecologists to characterize the extent and severity of anogenital HPV disease, which was also compared with affected males.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A 17-year retrospective review of medical records, including laboratory, histopathology and cytopathology records was performed for patients diagnosed with <jats:italic>GATA2<\/jats:italic> haploinsufficiency followed at the National Institutes of Health. Student\u2019s <jats:italic>t<\/jats:italic>-test and Mann-Whitney U test or Fisher\u2019s exact test were used to compare differences in continuous or categorical variables, respectively. Spearman\u2019s rho coefficient was employed for correlations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 68 patients with <jats:italic>GATA2<\/jats:italic> haploinsufficiency, HPV disease was the initial manifestation in 27 (40%). HPV occurred at median 18.9 (15.2-26.2) years in females, and 25.6 (23.4-26.9) years in males. Fifty-two (76%), 27 females and 25 males, developed HPV-related squamous intraepithelial lesions (SIL) including two males with oral cancer. Twenty-one patients developed anogenital high-grade SIL (HSIL) or carcinoma (16 females versus 5 males, (59% versus 20%, respectively, p=0.005) at median 27 (18.6-59.3) years for females and 33 (16.5-40.1) years for males. Females were more likely than males to require &amp;gt;2 surgeries to treat recurrent HSIL (p=0.0009). Of 30 patients undergoing hematopoietic stem cell transplant (HSCT) to manage disease arising from <jats:italic>GATA2<\/jats:italic> haploinsufficiency, 12 (nine females, three males) had persistent HSIL\/HPV disease. Of these nine females, eight underwent peri-transplant surgical treatment of HSIL. Five of seven who survived post-HSCT received HPV vaccination and had no or minimal evidence of HPV disease 2 years post-HSCT. HPV disease persisted in two receiving immunosuppression. HPV disease\/low SIL (LSIL) resolved in all three males.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Females with <jats:italic>GATA2<\/jats:italic> haploinsufficiency exhibit a heightened risk of recurrent, multifocal anogenital HSIL requiring frequent surveillance and multiple treatments. <jats:italic>GATA2<\/jats:italic> haploinsufficiency must be considered in a female with extensive, multifocal genital HSIL unresponsive to multiple surgeries. This population may benefit from early intervention like HSCT accompanied by continued, enhanced surveillance and treatment by gynecologic oncologists and gynecologists in those with anogenital HPV disease.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1445711","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T04:50:57Z","timestamp":1724907057000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Human papillomavirus disease in GATA2 deficiency: a genetic predisposition to HPV-associated female anogenital malignancy"],"prefix":"10.3389","volume":"15","author":[{"given":"Ehren","family":"Dancy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Stratton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique C.","family":"Pichard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz E.","family":"Marciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward W.","family":"Cowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison A.","family":"McBride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koenraad","family":"Van Doorslaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Merideth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Salmeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marybeth S.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Parta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis D.","family":"Hickstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi H.","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa S.","family":"Zerbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-360313","article-title":"Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency","volume":"118","author":"Dickinson","year":"2011","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-05-356352","article-title":"Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome","volume":"118","author":"Hsu","year":"2011","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-08-2989","article-title":"Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis","volume":"106","author":"Rodrigues","year":"2005","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-06-2527","article-title":"Redirecting differentiation of hematopoietic progenitors by a transcription factor, GATA-2","volume":"107","author":"Kitajima","year":"2006","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-07-515528","article-title":"GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity","volume":"123","author":"Spinner","year":"2014","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.08.004","article-title":"Nonmyeloablative allogeneic hematopoietic stem cell transplantation for GATA2 deficiency","volume":"20","author":"Grossman","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.01.030","article-title":"Allogeneic hematopoietic stem cell transplantation for GATA2 deficiency using a busulfan-based regimen","volume":"24","author":"Parta","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"B8","doi-asserted-by":"publisher","first-page":"435 e1","DOI":"10.1016\/j.jtct.2020.12.028","article-title":"Hematopoietic cell transplantation and outcomes related to human papillomavirus disease in GATA2 deficiency","volume":"27","author":"Parta","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-208629","article-title":"Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia","volume":"115","author":"Vinh","year":"2010","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-07-517151","article-title":"The evolution of cellular deficiency in GATA2 mutation","volume":"123","author":"Dickinson","year":"2014","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.07.049","article-title":"Warts and all: human papillomavirus in primary immunodeficiencies","volume":"130","author":"Leiding","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-3868-2","article-title":"Genetic susceptibility to cervical cancer: role of common polymorphisms in apoptosis-related genes","volume":"36","author":"Tan","year":"2015","journal-title":"Tumour Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.07.055","article-title":"Global burden of human papillomavirus and related diseases","author":"Forman","year":"2012","journal-title":"Vaccine"},{"key":"B14","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"16086","DOI":"10.1038\/nrdp.2016.86","article-title":"Carcinogenic human papillomavirus infection","volume":"2","author":"Schiffman","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000001356","article-title":"Estimated prevalence and incidence of disease-associated human papillomavirus types among 15- to 59-year-olds in the United States","volume":"48","author":"Lewis","year":"2021","journal-title":"Sex Transm Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type","volume":"141","author":"de Martel","year":"2017","journal-title":"Int J Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31883","article-title":"Risk of CIN3 or worse with persistence of 13 individual oncogenic HPV types","volume":"144","author":"Sand","year":"2019","journal-title":"Int J Cancer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/jcm4020260","article-title":"HPV carcinomas in immunocompromised patients","volume":"4","author":"Reusser","year":"2015","journal-title":"J Clin Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2102715","article-title":"Treatment of relapsing HPV diseases by restored function of natural killer cells","volume":"385","author":"Lisco","year":"2021","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"14B 9 1","DOI":"10.1002\/cpmc.16","article-title":"Detection and genotyping of human papillomaviruses from archival formalin-fixed tissue samples","volume":"43","author":"Van Doorslaer","year":"2016","journal-title":"Curr Protoc Microbiol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/path.855","article-title":"Comparative analysis of human papillomavirus infections in cervical scrapes and biopsy specimens by general SPF(10) PCR and HPV genotyping","volume":"194","author":"Quint","year":"2001","journal-title":"J Pathol"},{"key":"B23","volume-title":"Applied Statistics for the Behavioral Sciences","author":"Hinkle","year":"2003"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1186\/1750-9378-4-8","article-title":"Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline","volume":"4","author":"Schiffman","year":"2009","journal-title":"Infect Agent Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/pon.3992","article-title":"The impact of surgery for vulval cancer upon health-related quality of life and pelvic floor outcomes during the first year of treatment: a longitudinal, mixed methods study","volume":"25","author":"Jones","year":"2016","journal-title":"Psychooncology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05543.x","article-title":"Recurrent \u2018sterile\u2019 verrucous cyst abscesses and epidermodysplasia verruciformis-like eruption associated with idiopathic CD4 lymphopenia","volume":"149","author":"Tobin","year":"2003","journal-title":"Br J Dermatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2010.184","article-title":"Human papillomavirus typing of verrucae in a patient with WHIM syndrome","volume":"146","author":"Palm","year":"2010","journal-title":"Arch Dermatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.04.039","article-title":"Human papillomavirus type 57 in generalized verrucosis without immunodeficiency","volume":"69","author":"Mendes Araujo","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.02.1118","article-title":"Generalized verrucosis and HPV-3 susceptibility associated with CD4 T-cell lymphopenia caused by inherited human interleukin-7 deficiency","volume":"72","author":"Horev","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-7-71","article-title":"Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry","volume":"7","author":"Beaussant Cohen","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002052","article-title":"Committee opinion no. 704: human papillomavirus vaccination","volume":"129","year":"2017","journal-title":"Obstet Gynecol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1001\/jamaoncol.2019.6722","article-title":"Immune response following quadrivalent human papillomavirus vaccination in women after hematopoietic allogeneic stem cell transplant: A nonrandomized clinical trial","volume":"6","author":"Stratton","year":"2020","journal-title":"JAMA Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit170","article-title":"Natural history of anal vs oral HPV infection in HIV-infected men and women","volume":"208","author":"Beachler","year":"2013","journal-title":"J Infect Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1086\/421467","article-title":"Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type","volume":"190","author":"Moscicki","year":"2004","journal-title":"J Infect Dis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.3390\/cells10113104","article-title":"NK cell regulation in cervical cancer and strategies for immunotherapy","volume":"10","author":"Gutierrez-Hoya","year":"2021","journal-title":"Cells"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-09-453969","article-title":"Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset","volume":"121","author":"Mace","year":"2013","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw160","article-title":"Association of GATA2 deficiency with severe primary epstein-barr virus (EBV) infection and EBV-associated cancers","volume":"63","author":"Cohen","year":"2016","journal-title":"Clin Infect Dis"},{"key":"B38","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/LGT.0000000000000468","article-title":"Guidelines for cervical cancer screening in immunosuppressed women without HIV infection","volume":"23","author":"Moscicki","year":"2019","journal-title":"J Low Genit Tract Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1445711\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T04:51:01Z","timestamp":1724907061000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1445711\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,29]]},"references-count":38,"alternative-id":["10.3389\/fimmu.2024.1445711"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1445711","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,29]]},"article-number":"1445711"}}